Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$90,080,497
-$8,273,905 QoQ
Shares Held
475,058
-4.7% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#129
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STATE OF WISCONSIN INVESTMENT BOARD holds $1,684,684,392 across 11 Drug Manufacturers - General names. AZN ranks #6 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
428,209 | $513,606,763 | |
| 2 | JNJ |
Johnson & Johnson
|
1,284,259 | $326,163,258 | |
| 3 | ABBV |
AbbVie Inc.
|
943,411 | $237,399,944 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,318,963 | $169,486,745 | |
| 5 | AMGN |
Amgen Inc
|
287,659 | $104,167,077 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
475,058 | $90,080,497 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
662,319 | $83,677,382 | |
| 8 | PFE |
Pfizer Inc
|
3,035,990 | $73,106,639 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $90,080,497 | 475,058 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $98,354,402 | 498,704 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||